1. Home
  2. TARS vs EVTC Comparison

TARS vs EVTC Comparison

Compare TARS & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • EVTC
  • Stock Information
  • Founded
  • TARS 2016
  • EVTC 1988
  • Country
  • TARS United States
  • EVTC United States
  • Employees
  • TARS N/A
  • EVTC N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • EVTC EDP Services
  • Sector
  • TARS Health Care
  • EVTC Technology
  • Exchange
  • TARS Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • TARS 2.1B
  • EVTC 2.0B
  • IPO Year
  • TARS 2020
  • EVTC 2013
  • Fundamental
  • Price
  • TARS $46.52
  • EVTC $32.60
  • Analyst Decision
  • TARS Strong Buy
  • EVTC Hold
  • Analyst Count
  • TARS 5
  • EVTC 3
  • Target Price
  • TARS $54.20
  • EVTC $35.00
  • AVG Volume (30 Days)
  • TARS 735.2K
  • EVTC 331.1K
  • Earning Date
  • TARS 02-25-2025
  • EVTC 02-26-2025
  • Dividend Yield
  • TARS N/A
  • EVTC 0.61%
  • EPS Growth
  • TARS N/A
  • EVTC N/A
  • EPS
  • TARS N/A
  • EVTC 1.28
  • Revenue
  • TARS $129,621,000.00
  • EVTC $823,712,000.00
  • Revenue This Year
  • TARS $917.88
  • EVTC $23.87
  • Revenue Next Year
  • TARS $78.70
  • EVTC $6.26
  • P/E Ratio
  • TARS N/A
  • EVTC $25.50
  • Revenue Growth
  • TARS 801.96
  • EVTC 24.45
  • 52 Week Low
  • TARS $20.08
  • EVTC $28.76
  • 52 Week High
  • TARS $57.14
  • EVTC $42.21
  • Technical
  • Relative Strength Index (RSI)
  • TARS 37.06
  • EVTC 37.97
  • Support Level
  • TARS $43.61
  • EVTC $31.44
  • Resistance Level
  • TARS $57.00
  • EVTC $33.24
  • Average True Range (ATR)
  • TARS 2.65
  • EVTC 0.68
  • MACD
  • TARS -1.27
  • EVTC -0.14
  • Stochastic Oscillator
  • TARS 21.51
  • EVTC 30.29

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.

Share on Social Networks: